Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interferon-induced sarcoidosis.

Ami N Rubinowitz1, David P Naidich, Cesar Alinsonorin

  • 1the Department of Radiology, New York University Medical Center, New York, NY 10016, USA. ami.rubinowitz@med.nyu.edu

Journal of Computer Assisted Tomography
|April 19, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Profibrotic monocyte-derived alveolar macrophages as a biomarker and therapeutic target in systemic sclerosis-associated interstitial lung disease.

bioRxiv : the preprint server for biology·2025
Same author

Lung Cancer with Cystic Airspace: An Overview.

Seminars in respiratory and critical care medicine·2025
Same author

Li-Fraumeni Syndrome: Imaging Features and Guidelines.

Radiographics : a review publication of the Radiological Society of North America, Inc·2024
Same author

Diseases Involving the Lung Peribronchovascular Region: A CT Imaging Pathologic Classification.

Chest·2024
Same author

Disorders with Ophthalmic and Thoracic Involvement.

Radiographics : a review publication of the Radiological Society of North America, Inc·2024
Same author

Assistive AI in Lung Cancer Screening: A Retrospective Multinational Study in the United States and Japan.

Radiology. Artificial intelligence·2024
Same journal

Low-Field Neuroimaging: Opportunities and Limitations.

Journal of computer assisted tomography·2026
Same journal

Diagnostic Performance of Routine Abdominal MRI for Detecting Left Ventricular Hypertrophy in ADPKD.

Journal of computer assisted tomography·2026
Same journal

Evaluation of Gd-EOB-DTPA MRI With Diffusion and Clinicopathologic Features for Predicting Microvascular Invasion in Hepatocellular Carcinoma.

Journal of computer assisted tomography·2026
Same journal

Artificial Intelligence for Opportunistic Screening for Osteoporosis and Spine Fractures Using Computed Tomography: A Systematic Review and Meta-Analysis.

Journal of computer assisted tomography·2026
Same journal

Accuracy and Variability of Spatial Localization of Infarct Core Predicted by CT Perfusion.

Journal of computer assisted tomography·2026
Same journal

Acute Biliary Disorders and Complications.

Journal of computer assisted tomography·2026
See all related articles

Interferon therapy for hepatitis C can rarely cause sarcoidosis. This study documents two cases, highlighting the need for physician awareness of this uncommon side effect to guide patient management.

Area of Science:

  • Immunology
  • Pulmonology
  • Hepatology

Background:

  • Interferons are utilized in treating various diseases, including hepatitis C virus (HCV) infection.
  • While common side effects are typically constitutional, pulmonary complications are rare.
  • Sarcoidosis is an inflammatory condition that can affect multiple organs.

Observation:

  • Two cases of sarcoidosis developed in patients undergoing interferon therapy for HCV.
  • This association is infrequently reported in medical literature.
  • The onset of sarcoidosis occurred during interferon treatment for hepatitis C.

Findings:

  • Interferon therapy is associated with the rare development of sarcoidosis.
  • Pulmonary sarcoidosis can manifest as an adverse effect of interferon treatment.

Related Experiment Videos

  • The presented cases add to the limited documented evidence of this interferon-sarcoidosis link.

    • Implications:

    • Physicians should consider sarcoidosis in patients on interferon therapy presenting with relevant symptoms.
    • Awareness of this association may prevent unnecessary invasive diagnostic procedures.
    • Early recognition and diagnosis of interferon-induced sarcoidosis can optimize patient care and treatment strategies.